ASND Ascendis Pharma A/S
- 136.080
- -0.235-0.17%
- 136.080
- 0.0000.00%
Ascendis Pharma A/S News
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 20-F: FY2023 Annual Report
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 20-F: FY2022 Annual Report
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Analysis
Price Target
No Data
No Data